News
Hybrid and plug-in hybrid (PHEV) cars can deliver exceptional fuel economy and a familiar driving experience. Here are the ...
In addition to its V8 petrol engine, Ferrari’s ... As for a successor? Well, the F80 hypercar is here, albeit as an uber-flagship in the tyre tracks of LaFerrari, Enzo and F50, rather than ...
Lewis Hamilton revealed an element of his Ferrari SF-25 has been identified as “underperforming”, which will be fixed on his car. The seven-time World Champion finished seventh in the Japanese ...
A great looking example of the Ferrari 456M GTA has changed hands for $55,000. The 2+2 grand tourer has an automatic gearbox and just 30,000 miles on the clock. The price is tempting, despite the ...
3d
Top Gear on MSNYou can now buy a Hot Wheels Ferrari F40, F50 and LaFerrariUse precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
SUZUKA, Japan, April 6 (Reuters) - Ferrari's anticipated title challenge again failed to materialise at the Japanese Grand Prix with Charles Leclerc finishing in fourth place, Lewis Hamilton in ...
Raut suggested RSS might choose Modi's successor after his meeting with Mohan Bhagwat, hinting at a potential retirement due to age. Fadnavis countered, emphasizing it's inappropriate to discuss ...
Lewis Hamilton wants to see “positive changes” from Ferrari at the Bahrain Grand Prix after suggesting his car is underperforming compared to team-mate Charles Leclerc. It was another ...
Lewis Hamilton has confirmed that Ferrari have found an issue with their car but is hopeful of a remedy for the next race in Bahrain. The seven-time F1 world champion, who qualified eighth on the ...
Even Ferrari is set to unveil an EV sometime this year! Buyers who fancy some internal combustion muscle won’t be starved for choice though, as coming soon is the eagerly anticipated Dacia ...
Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2b data. The latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results